Search - tctmd.com

Displaying 281 - 300 of 963

Sort: Relevancy | Date

News Conference News TVT 2022

More Support for Single Antiplatelet Therapy After TAVI

Michael O'Riordan

June 10, 2022

News Conference News TVT 2022

No Stroke Reduction With Embolic Protection in TAVI, Two Studies Suggest

Michael O'Riordan

June 09, 2022

Presentation TVT 2022

Percutaneous Debulking of a Mitral Valve Mass in a Patient Presenting with Recurrent Stroke

Presenter: Nahyr Lugo-Fagundo

June 09, 2022

Presentation TVT 2022

Cerebral Embolic Protection and Severity of Stroke Following Transcatheter Aortic Valve Replacement

Presenter: Toshiaki Isogai

June 09, 2022

Presentation TVT 2022

Percutaneous Debulking of a Mitral Valve Mass in a Patient Presenting With Recurrent Stroke

Presenter: Nahyr Lugo-Fagundo

June 09, 2022

News Daily News

LAA Occlusion With Watchman Provides Good Early Results in China

Todd Neale

June 07, 2022

News Conference News EuroPCR 2022

Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN

Caitlin E. Cox

May 27, 2022

News Conference News EuroPCR 2022

Next-Generation Navitor Valve Shows Promise in High-risk TAVI Patients

Yael L. Maxwell

May 27, 2022

News Conference News EAS 2022

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

Michael O'Riordan

May 24, 2022

News Conference News EuroPCR 2022

Thrombotic vs Bleeding Risks Post-TAVI: Insights From GALILEO

Yael L. Maxwell

May 23, 2022

News Conference News SCAI 2022

SCAI PFO Closure Guideline Addresses Real-world Patient Scenarios

L.A. McKeown

May 20, 2022

News Conference News EuroPCR 2022

MitraClip ‘Bridge’ Strategy Continues to Help Sickest HF Patients

Michael O'Riordan

May 20, 2022

News Conference News EuroPCR 2022

TriCLASP: Tricuspid Repair With Pascal Safe, Effective at 30 days

Yael L. Maxwell

May 19, 2022

News Conference News EuroPCR 2022

JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use

Caitlin E. Cox

May 18, 2022

News Daily News

Risk of Repeat Stroke Underrecognized in Nonstenotic Carotid Lesions

L.A. McKeown

May 06, 2022

News Daily News

NCDR Analyses Offer Insights Into First-Generation Watchman Outcomes

L.A. McKeown

May 03, 2022

News Conference News HRS 2022

Registry Shows Watchman FLX Beating First-Gen Device for Early LAAO Outcomes

Todd Neale

May 02, 2022

News Opinion CV Team Dispatch

May 2022 News Roundup

L.A. McKeown

May 01, 2022

News Conference News ACC 2022

ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI

Todd Neale

April 05, 2022

News Conference News ACC 2022

Tricuspid Repair With Pascal Safe, Effective at 1 Year: CLASP TR

Yael L. Maxwell

April 05, 2022

Advertisement

More Support for Single Antiplatelet Therapy After TAVI

No Stroke Reduction With Embolic Protection in TAVI, Two Studies Suggest

Percutaneous Debulking of a Mitral Valve Mass in a Patient Presenting with Recurrent Stroke

Cerebral Embolic Protection and Severity of Stroke Following Transcatheter Aortic Valve Replacement

Percutaneous Debulking of a Mitral Valve Mass in a Patient Presenting With Recurrent Stroke

LAA Occlusion With Watchman Provides Good Early Results in China

Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN

Next-Generation Navitor Valve Shows Promise in High-risk TAVI Patients

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

Thrombotic vs Bleeding Risks Post-TAVI: Insights From GALILEO

SCAI PFO Closure Guideline Addresses Real-world Patient Scenarios

MitraClip ‘Bridge’ Strategy Continues to Help Sickest HF Patients

TriCLASP: Tricuspid Repair With Pascal Safe, Effective at 30 days

JenaValve Trilogy Meets the Challenge of AR in Early Real-World Use

Risk of Repeat Stroke Underrecognized in Nonstenotic Carotid Lesions

NCDR Analyses Offer Insights Into First-Generation Watchman Outcomes

Registry Shows Watchman FLX Beating First-Gen Device for Early LAAO Outcomes

May 2022 News Roundup

ADAPT-TAVR: Edoxaban No Better Than DAPT After TAVI

Tricuspid Repair With Pascal Safe, Effective at 1 Year: CLASP TR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content